{"database": "openregs", "table": "documents", "rows": [["FDA-1999-D-0010-0002", "FDA", "FDA-1999-D-0010", "Guidance for Industry on Levothyroxine Sodium Tablets-In Vivo Pharmacokinetic and Bioavailability Studies and in Vitro Dissolution Testing; Availability", "Notice", "Notice of Data Availability", "2001-03-09T00:00:00Z", 2001, 3, null, null, "2025-05-27T16:19:59Z", "01-5610", 0, 0, "09000064804a59f2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1999-D-0010-0002"], "units": {}, "query_ms": 0.9244438260793686, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}